Air Medical Journal
Volume 25, Issue 2 , Pages 85-87 , March 2006

Case report of unrecognized akathisia resulting in an emergency landing and RSI during air medical transport

  • Darren Braude, MD, MPH, EMT-P

      Affiliations

    • Corresponding Author InformationAddress for correspondence, Darren Braude, MD, EMT-P, Department of Emergency Medicine, MSC 10-5560, University of New Mexico, Albuquerque, NM 87131-0001
    • ,
  • Sandy Boling, RN

References 

  1. Leong G , Silva J . Neuroleptic-induced akathisia and violence: a review . J Forensic Sci . 2003;48(1):187–189
  2. Hansen L . A critical review of akathisia, and its possible association with suicidal behaviour . Hum Psychopharmacol . 2001;16(7):495–505
  3. Poyurovsky M , Weizman A . Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: a new approach to an old problem . Br J Psychiatry . 2001;179:4–8
  4. Blaisdell G . Akathisia: a comprehensive review and treatment summary . Pharmacopsychiatry . 1994;27(4):139–146
  5. Lindenmayer JP . The pathophysiology of agitation . J Clin Psychiatry . 2000;61(suppl 14):5–110
  6. Drotts D , Vinson D . Prochlorperazine induces akathisia in emergency patients . Ann Emerg Med . 1999;34(4 Pt 1):469–475
  7. Van Putten T , May PR , Marder SR . Akathisia with haloperidol and thiothixine . Arch Gen Psychiatry . 1984;41(11):1036–1039
  8. Sachdev P . The epidemiology of drug-induced akathisia: Part I. Acute akathisia . Schizophr Bull . 1995;21(3):431–449
  9. Walker L . Sertraline-induced akathisia and dystonia misinterpreted as a panic attack . Psychiatr Serv . 2002;53(11):1477–1478
  10. Hirose S . The causes of underdiagnosing akathisia . Schizophr Bull . 2003;29(3):547–558
  11. Barnes TR . A rating scale for drug-induced akathisia . Br J Psychiatry . 1989;154:672–676
  12. Jung H , Kim J , Ahn Y , Kim S , Hwang S , Kim Y . Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) as a subjective measure of drug-induced parkinsonism and akathisia . Hum Psychopharmacol . 2005;20(1):41–45
  13. Masui T , Kusumi I , Takahashi Y , Koyama T . Efficacy of carbamazepine against neuroleptic-induced akathisia in treatment with perospirone: case series . Prog Neuropsychopharmacol Biol Psychiatry . 2005;29(2):343–346
  14. Pfeffer G , Chouinard G , Margolese HC . Gabapentin in the treatment of antipsychotic-induced akathisia in schizophrenia . Int Clin Psychopharmacol . 2005;20(3):179–181
  15. Stryjer R , Strous R , Bar F , Poyurovsky M , Weizman A , Kotler M . Treatment of neuroleptic-induced akathisia with the 5-HT2A antagonist trazodone . Clin Neuropharmacol . 2003;26(3):137–141
  16. Lerner V , Bergman J , Statsenko N , Miodownik C . Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study . J Clin Psychiatry . 2004;65(11):1550–1554
  17. Gross-Isseroff R , Magen A , Shiloh R , Hermesh H , Weizman A . The 5-HT1D receptor agonist zolmitriptan for neuroleptic-induced akathisia: an open label preliminary study . Int Clin Psychopharmacol . 2005;20(1):23–25
  18. Vinson D . Diphenhydramine in the treatment of akathisia induced by prochlorperazine . J Emerg Med . 2004;26(3):265–270
  19. Lima A , Weiser K , Bacaltchuk J , Barnes T . Anticholinergics for neuroleptic-induced acute akathisia . Cochrane Database Syst Rev . 2004;(1): CD003727
  20. Miller CH , Fleischhacker WW . Managing antipsychotic-induced acute and chronic akathisia . Drug Safety . 2000;22(1):73–81
  21. Lima A , Bacalcthuk J , Barnes T , Soares-Weiser K . Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia . Cochrane Database Syst Rev . 2004;(4): CD001946
  22. Lima A , Soares-Weiser K , Bacaltchuk J , Barnes T . Benzodiazepines for neuroleptic-induced acute akathisia . Cochrane Database Syst Rev . 2002;(1): CD001950
  23. Vinson D , Drotts D . Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial . Ann Emerg Med . 2001;37(2):125–131
  24. Collins R , Jones J , Walthall J , et al.   Intravenous administration of prochlorperazine by 15-minute infusion versus 2-minute bolus does not affect the incidence of akathisia: a prospective, randomized, controlled trial . Ann Emerg Med . 2001;38(5):491–496
  25. Vinson D , Migala A , Quesenberry C . Slow infusion for the prevention of akathisia induced by prochlorperazine: a randomized controlled trial . J Emerg Med . 2001;20(2):113–119
  26. Rodnitzky RL . Drug-induced movement disorders in children and adolescents . Expert Opin Drug Saf . 2005;4(1):91–102
  27. Gogtay N , Sporn A , Alfaro CL , Mulqueen A , Rapoport JL . Clozapine-induced akathisia in children with schizophrenia . J Child Adolesc Psychopharmacol . 2002;12(4):347–349

 PHI Air Medical of New MexicoDisclosureDarren Braude receives unrestricted research funding from GlaxoSmithKline, the manufacturers of ondansetron (Zofran).

PII: S1067-991X(05)00222-1

doi: 10.1016/j.amj.2005.12.002

Air Medical Journal
Volume 25, Issue 2 , Pages 85-87 , March 2006

Article Tools